Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VEDOLIZUMAB Cause Complication associated with device? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Complication associated with device have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.0% of all adverse event reports for VEDOLIZUMAB.

26
Reports of Complication associated with device with VEDOLIZUMAB
0.0%
of all VEDOLIZUMAB reports
0
Deaths
16
Hospitalizations

How Dangerous Is Complication associated with device From VEDOLIZUMAB?

Of the 26 reports, 16 (61.5%) required hospitalization, and 1 (3.8%) were considered life-threatening.

Is Complication associated with device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does VEDOLIZUMAB Cause?

Off label use (21,017) Colitis ulcerative (13,455) Crohn's disease (9,759) Drug ineffective (8,424) Diarrhoea (7,493) Abdominal pain (6,401) Fatigue (5,477) Haematochezia (5,215) Frequent bowel movements (4,527) Arthralgia (4,028)

What Other Drugs Cause Complication associated with device?

ETONOGESTREL (6,047) COPPER (1,083) BACLOFEN (525) TREPROSTINIL (422) EPOPROSTENOL (399) LEVONORGESTREL (344) ADALIMUMAB (269) CARBIDOPA\LEVODOPA (169) MACITENTAN (169) TEDUGLUTIDE (133)

Which VEDOLIZUMAB Alternatives Have Lower Complication associated with device Risk?

VEDOLIZUMAB vs VELAGLUCERASE ALFA VEDOLIZUMAB vs VELCADE VEDOLIZUMAB vs VELETRI VEDOLIZUMAB vs VELIPARIB VEDOLIZUMAB vs VEMURAFENIB

Related Pages

VEDOLIZUMAB Full Profile All Complication associated with device Reports All Drugs Causing Complication associated with device VEDOLIZUMAB Demographics